OncoZenge (Q3 Review): Concrete partnering interest, but recruitment slower than anticipated
2026-11-12 12:00:00
Redeye’s analyst published a Research Update on OncoZenge.
Click here to read the article
Make sure to add OncoZenge to your Watchlist at Redeye and our analysts will notify you if anything relevant happens regarding your companies